Showing results (1-10 of 56) with videos related to
Sort By:
Pageof 6
GEN Biotechnology|June 16, 2022
Advancing the Research and Development of Enzyme Replacement Therapies for Lysosomal Storage DiseasesAna C Puhl, Sean EkinsPharmaceutical Research|June 13, 2020
Repurposing the Dihydropyridine Calcium Channel Inhibitor Nicardipine as a Nav1.8 Inhibitor In Vivo for Pitt Hopkins SyndromeSean Ekins, Ana C Puhl, Audrey DavidowData in Brief|October 21, 2016
Structural dataset for the PPARγ V290M mutantAna C Puhl, Paul Webb, Igor PolikarpovCurrent Opinion in Chemical Biology|July 18, 2021
Recent advances in drug repurposing using machine learningFabio Urbina, Ana C Puhl, Sean EkinsDrug Discovery Today|July 23, 2023
Learning from COVID-19: How drug hunters can prepare for the next pandemicAna C Puhl, Thomas R Lane, Sean EkinsXenobiotica; the Fate of Foreign Compounds in Biological Systems|August 4, 2023
In silico ADME/tox comes of age: twenty years laterSean Ekins, Thomas R Lane, Fabio Urbina, et al.Frontiers in Pharmacology|July 11, 2022
Machine Learning for Discovery of New ADORA ModulatorsAna C Puhl, Zhan-Guo Gao, Kenneth A Jacobson, et al.GEN Biotechnology|October 6, 2025
Developing Treatments for Rare Diseases on a ShoestringAna C Puhl, Sarah Negri, Maggie A Z Hupcey, et al.Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|February 7, 2013
Crystallization and preliminary diffraction analysis of the catalytic domain of major extracellular endoglucanase from Xanthomonas campestris pv. campestrisFlávio R Rosseto, Ana C Puhl, Maxuel O Andrade, et al.Drug Discovery Today|March 20, 2019
New targets for HIV drug discoveryAna C Puhl, Alfredo Garzino Demo, Vadim A Makarov, et al.Pageof 6